Akira Endo

Akira Endo is a pioneering Japanese biochemist renowned for his groundbreaking discovery of the first statin, a class of drugs that revolutionized the treatment of hypercholesterolemia and cardiovascular disease. His research, initiated in the 1970s while working for the pharmaceutical company Sankyo, led to the isolation of compactin (mevastatin) from the fungus Penicillium citrinum. This discovery provided the foundational mechanism for inhibiting HMG-CoA reductase, a key enzyme in the cholesterol biosynthesis pathway, and has had a profound global impact on preventive medicine.

Early life and education

Born in rural Yurihonjō, Akita Prefecture, he developed an early interest in the natural world, particularly fungi and fermentation. He pursued higher education in biochemistry at Tohoku University in Sendai, where he earned his undergraduate and doctoral degrees. His graduate research focused on enzymology, studying the properties of cellulase enzymes, which laid a crucial foundation for his later investigative work in microbial metabolism. After completing his PhD in 1966, he accepted a position as a research scientist at the Sankyo Company in Tokyo, seeking to apply his knowledge to drug discovery.

Discovery of statins

At Sankyo in the early 1970s, he embarked on a systematic search for microbial compounds that could inhibit cholesterol synthesis, hypothesizing that such an agent could treat atherosclerosis. Screening over 6,000 fungal extracts, his team identified a potent inhibitor produced by Penicillium citrinum in 1973. This compound, initially named ML-236B and later called compactin or mevastatin, was shown to be a highly specific competitive inhibitor of the enzyme HMG-CoA reductase. The subsequent work, published in prestigious journals like FEBS Letters and the Journal of Antibiotics, demonstrated that compactin could dramatically lower plasma cholesterol levels in animal models, validating the therapeutic concept.

Research and career

Following the discovery of compactin, his research faced initial skepticism and internal challenges at Sankyo, delaying clinical development. Nevertheless, his published work inspired other pharmaceutical firms, including Merck & Co., to launch their own discovery programs, leading to the development of lovastatin and simvastatin. He continued his prolific research career, investigating other bioactive compounds from fungi and plants. After retiring from Sankyo, he served as a professor at the Tokyo University of Agriculture and Technology, mentoring future scientists and continuing his exploration of microbial metabolites. His later work also contributed to the understanding of cholesterol metabolism and isoprenoid biosynthesis.

Awards and honors

His seminal contributions have been recognized with numerous international awards. He received the prestigious Japan Prize in 2006 for his work on the "development of statins." In 2008, he was a co-recipient of the Lasker-DeBakey Clinical Medical Research Award, often considered a precursor to the Nobel Prize. Further accolades include the Heinrich Wieland Prize (1987), the Massry Prize (2006), and the Canada Gairdner International Award in 2017. He is also a foreign associate of the U.S. National Academy of Sciences and has received honors from the Japanese Society of Chemotherapy and the American College of Cardiology.

Legacy and impact

The discovery of statins is considered one of the most important advances in modern pharmacology and clinical medicine. These drugs have become the cornerstone of therapy for preventing myocardial infarction, stroke, and other manifestations of atherosclerotic cardiovascular disease, saving millions of lives worldwide. His pioneering approach of screening microbial metabolites for specific enzyme inhibition has influenced countless other drug discovery campaigns. His story is a testament to the profound impact of fundamental, curiosity-driven industrial research, and he is widely regarded as the father of a therapeutic class that transformed global public health.

Category:Japanese biochemists Category:1933 births Category:Living people Category:Japan Prize laureates Category:Statin researchers